Page results
-
Watch our short patient information videos on dementia
-
Researchers at the NIHR UCLH Clinical Research Facility are the first in the world to start a new first-in-human trial investigating a novel treatment, called NVG-111, in patients with Non-Hodgkin lymphoma (NHL) subtypes.
-
University College Hospital's Outpatients department sees many patients, covering a variety of different specialties.
-
UCLH has moved one step closer to carbon net zero emissions with the installation of six new mobile Entonox destructions units across our birthing centre and labour wards.
-
On Wednesday 29th March, governors Mick Goss and Fiona McLean arranged for governors to visit the National Hospital for Neurology and Neurosurgery (NHNN) at Queen Square.
-
Contact details of clinical lead adults and lead paediatrics
-
UCLH and The Francis Crick Institute have formed a partnership to deliver a new large-scale COVID-19 vaccination centre at the Institute.
-
Achilles Therapeutics, a company built on research at UCLH, UCL Cancer Institute and the Francis Crick Institute has successfully raised $175.5 million through its initial public offering in the United States.
-
COVID-19 vaccines are effective for most cancer patients but the level of protection offered by vaccines against infection, hospitalisation and death is lower compared with the general population and also wanes more quickly, according to a study in which UCLH participated.
-
The Government has now set out further action aimed at tackling rising cases of the COVID-19 B1.617.2 variant of COVID-19 (also known as the Indian variant).
File results
-
FOI/2022/0546 - Metastatic Cholangiocarcinoma (CCA) or Acute myeloid leukaemia
-
FOI/2022/0548 - Biologic and biosimilar products within Rheumatology
-
FOI/2022/0549 - SACT (systemic anti-cancer therapy) /cervical cancer treatments
-
FOI/2022/0550 - Patients that have been treated for glioblastoma brain cancer
-
FOI/2022/0553 - Patients tested for non-small cell lung cancer biomarkers
-
FOI/2022/0561 - Regulation (EU) 2016/425 Declarations of Conformity for all type IIR surgical masks provided as PPE to staff
-
FOI/2022/0571 - Treatment for biologic medicines in Dermatology
-
FOI/2022/0572 - Treatments for Hidradenitis Suppurativa and Psoriasis
-
FOI/2022/0573 - Use of WhatsApp by or within the Trust
-
FOI/2022/0513 - Myelofibrosis treatment